Nova Patents
AT343374T

Pharmaceutical formulation of fluticasone propionate

Abstract

A pharmaceutical aerosol formulation comprising: (i) fluticasone propionate; (Ii) a hydrofluoroalkane propellant (HFA); and (iii) ethanol; It characterized in that the fluticasone propionate is completely dissolved in the formulation.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

54 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
9921396United KingdomA
9921396United KingdomA
0014451United KingdomA
0014451United KingdomA
0018654United KingdomA
0018654United KingdomA
0014451–––
0018654–––
9921396–––
GB19990021396–––
GB20000014451–––
GB20000018654–––

Members54

Family members, oldest first
DocumentOfficeKind
GB9921396D0United KingdomD0
GB0014451D0United KingdomD0
ITRM20000491A0ItalyA0
ITRM20000491D0ItalyD0
GB0018654D0United KingdomD0
GB0022222D0United KingdomD0
CA2317999A1CanadaA1
CA2446562A1CanadaA1
CA2486805A1CanadaA1
GB2354007AUnited KingdomA
FR2798290A1FranceA1
WO0119342A2World Intellectual Property Organization (WIPO)A2
AU7026800AAustraliaA
WO0119342A3World Intellectual Property Organization (WIPO)A3
EP1143930A2European Patent Office (EPO)A2
ITRM20000491A1ItalyA1
FR2820322A1FranceA1
EP1143930A3European Patent Office (EPO)A3
US6479035B1United States of AmericaB1
JP2003509359AJapanA
US2003086876A1United States of AmericaA1
GB0312326D0United KingdomD0
IT1317904B1ItalyB1
GB2385596AUnited KingdomA
FR2798290B1FranceB1
GB0320477D0United KingdomD0
US6630129B2United States of AmericaB2
GB2354007BUnited KingdomB
GB2388843AUnited KingdomA
GB0328426D0United KingdomD0
GB0328773D0United KingdomD0
GB2392164AUnited KingdomA
US2004037783A1United States of AmericaA1
GB2385596BUnited KingdomB
GB2388843BUnited KingdomB
FR2843882A1FranceA1
GB2392915AUnited KingdomA
GB2392164BUnited KingdomB
GB2392915BUnited KingdomB
FR2848453A1FranceA1
US2004157815A1United States of AmericaA1
CA2317999CCanadaC
CA2446562CCanadaC
FR2820322B1FranceB1
EP1143930B1European Patent Office (EPO)B1
AT343374TThis recordAustriaT
ATE343374T1AustriaT1
DE60031504D1GermanyD1
DE60031504T2GermanyT2
US7220403B2United States of AmericaB2
ES2274803T3SpainT3
EP1143930B8European Patent Office (EPO)B8
FR2848453B1FranceB1
FR2843882B1FranceB1